These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 24931673)

  • 21. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
    Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.
    Kokić S; Buković D; Radman M; Capkun V; Gabrić N; Lesko V; Karelović D; Stancerić T
    Coll Antropol; 2003 Jun; 27(1):181-7. PubMed ID: 12974145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic effects of combined sulphonylurea and metformin therapy in maturity-onset diabetice.
    Nattrass M; Hinks L; Smythe P; Todd PG; Alberti KG
    Horm Metab Res; 1979 May; 11(5):332-7. PubMed ID: 573232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combination treatment with insulin and metformin in type 2 diabetes. Improves glycemic control and prevents weight gain].
    Hermann LS; Melander A
    Lakartidningen; 1999 Dec; 96(50):5616-9. PubMed ID: 10643226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mathematical Modeling of the Blood Glucose Regulation System in Diabetes Mellitus Patients].
    Karpel'ev VA; Filippov YI; Tarasov YV; Boyarsky MD; Mayorov AY; Shestakova MV; Dedov II
    Vestn Ross Akad Med Nauk; 2015; (5):549-60. PubMed ID: 26846080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-coated gold nanoparticles as a new concept for personalized and adjustable glucose regulation.
    Shilo M; Berenstein P; Dreifuss T; Nash Y; Goldsmith G; Kazimirsky G; Motiei M; Frenkel D; Brodie C; Popovtzer R
    Nanoscale; 2015 Dec; 7(48):20489-96. PubMed ID: 26583784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A model for multiple subcutaneous insulin injections developed from individual diabetic patient data.
    Puckett WR; Lightfoot EN
    Am J Physiol; 1995 Dec; 269(6 Pt 1):E1115-24. PubMed ID: 8572205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An integrated graphic scheme for the display of insulin prescription and blood glucose information.
    Kim MI
    Diabetes Technol Ther; 2006 Aug; 8(4):505-12. PubMed ID: 16939375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Numerical bifurcation analysis of delay differential equations arising from physiological modeling.
    Engelborghs K; Lemaire V; Bélair J; Roose D
    J Math Biol; 2001 Apr; 42(4):361-85. PubMed ID: 11374125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Personalized therapy for diabetes in retrospect and prospect].
    Tkáč I
    Vnitr Lek; 2014 Sep; 60(9):797-800. PubMed ID: 25294772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. All in good time. Does the time of day you exercise matter in blood glucose management?
    Diabetes Forecast; 2015; 68(2):19-20, 22. PubMed ID: 25815396
    [No Abstract]   [Full Text] [Related]  

  • 32. Delay-induced uncertainty in the glucose-insulin system: Pathogenicity for obesity and type-2 diabetes mellitus.
    Karamched BR; Hripcsak G; Leibel RL; Albers D; Ott W
    Front Physiol; 2022; 13():936101. PubMed ID: 36117719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple-Input Subject-Specific Modeling of Plasma Glucose Concentration for Feedforward Control.
    Kotz K; Cinar A; Mei Y; Roggendorf A; Littlejohn E; Quinn L; Rollins DK
    Ind Eng Chem Res; 2014 Nov; 53(47):18216-18225. PubMed ID: 25620845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulfonylurea: Personalized Medicine for Type 2 Diabetes.
    Hwang YC
    Endocrinol Metab (Seoul); 2015 Dec; 30(4):467-8. PubMed ID: 26790382
    [No Abstract]   [Full Text] [Related]  

  • 35. Multi-Timescale Rhythmicity of Blood Glucose and Insulin Delivery Reveals Key Advantages of Hybrid Closed Loop Therapy.
    Grant AD; Lewis DM; Kriegsfeld LJ
    J Diabetes Sci Technol; 2022 Jul; 16(4):912-920. PubMed ID: 33719596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delay-induced uncertainty for a paradigmatic glucose-insulin model.
    Karamched B; Hripcsak G; Albers D; Ott W
    Chaos; 2021 Feb; 31(2):023142. PubMed ID: 33653035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simulation and qualitative analysis of glucose variability, mean glucose, and hypoglycemia after subcutaneous insulin therapy for stress hyperglycemia.
    Strilka RJ; Stull MC; Clemens MS; McCaver SC; Armen SB
    Theor Biol Med Model; 2016 Jan; 13():3. PubMed ID: 26819233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of personalized diabetes treatment plans using a two-delay model.
    Kissler SM; Cichowitz C; Sankaranarayanan S; Bortz DM
    J Theor Biol; 2014 Oct; 359():101-11. PubMed ID: 24931673
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.